These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11771748)

  • 1. The brain in Down syndrome.
    Seidl R; Cairns N; Lubec G
    J Neural Transm Suppl; 2001; (61):247-61. PubMed ID: 11771748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of gene expression in Down's syndrome (DS) brains: its significance in neurodegeneration.
    Sawa A
    J Neural Transm Suppl; 2001; (61):361-71. PubMed ID: 11771759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration.
    de la Monte SM
    J Neural Transm Suppl; 1999; 57():1-19. PubMed ID: 10666665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.
    Holtzman DM; Santucci D; Kilbridge J; Chua-Couzens J; Fontana DJ; Daniels SE; Johnson RM; Chen K; Sun Y; Carlson E; Alleva E; Epstein CJ; Mobley WC
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13333-8. PubMed ID: 8917591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome.
    Opazo P; Saud K; de Saint Pierre M; Cárdenas AM; Allen DD; Segura-Aguilar J; Caviedes R; Caviedes P
    J Neurosci Res; 2006 Nov; 84(6):1303-10. PubMed ID: 16941497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21.
    Becker LE; Mito T; Takashima S; Onodera K; Friend WC
    APMIS Suppl; 1993; 40():57-70. PubMed ID: 8311992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.
    Contestabile A; Benfenati F; Gasparini L
    Prog Neurobiol; 2010 May; 91(1):1-22. PubMed ID: 20097253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression in Down syndrome brain.
    Engidawork E; Lubec G
    Amino Acids; 2001 Dec; 21(4):331-61. PubMed ID: 11858695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and neural dysfunction in Down syndrome.
    Iannello RC; Crack PJ; de Haan JB; Kola I
    J Neural Transm Suppl; 1999; 57():257-67. PubMed ID: 10666681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular changes in fetal Down syndrome brain.
    Engidawork E; Lubec G
    J Neurochem; 2003 Mar; 84(5):895-904. PubMed ID: 12603815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological phenotypes for Down syndrome across the life span.
    Lott IT
    Prog Brain Res; 2012; 197():101-21. PubMed ID: 22541290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurobiologic consequences of Down syndrome.
    Coyle JT; Oster-Granite ML; Gearhart JD
    Brain Res Bull; 1986 Jun; 16(6):773-87. PubMed ID: 2875770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and development of the brain in Down syndrome.
    Becker L; Mito T; Takashima S; Onodera K
    Prog Clin Biol Res; 1991; 373():133-52. PubMed ID: 1838182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomal abnormalities related to amyloid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome.
    Arriagada C; Astorga C; Atwater I; Rojas E; Mears D; Caviedes R; Caviedes P
    Neurosci Lett; 2007 Aug; 423(2):172-7. PubMed ID: 17706358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP.
    Millan Sanchez M; Heyn SN; Das D; Moghadam S; Martin KJ; Salehi A
    Biol Psychiatry; 2012 Mar; 71(5):403-9. PubMed ID: 21945306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of brain circuits in Down syndrome murine models.
    Gotti S; Caricati E; Panzica G
    J Chem Neuroanat; 2011 Dec; 42(4):317-26. PubMed ID: 21946025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.